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Dear Editor
Cotard’s syndrome (délire des negations), first described by Jules Cotard1-4, is defined as a  nihilistic 
delusion in which patient typically believes that he or she is dead, has lost his or her soul, has 
no functional body systems, or is rotting internally, or that the world no longer exists1-4. The 
syndrome is usually related to depression and is encountered in middle age or older people1. 
However, it can be seen in several other conditions and in younger patients1-4.
Mrs. A, a 55 year-old woman, was brought to our psychiatric emergency service because 
she hadn’t eaten or drank for the last two days. Her depressive symptoms had began 18 months 
before: she presented sadness, anhedonia and easy crying, which got progressively worse, with 
apathy, restlessness, prejudice in her daily activities, insomnia, weight loss (went from 105 kg to 
54 kg in one year) and delusional nihilistic thoughts. Outpatient care was initiated, but without 
result.
During evaluation, the patient had no eye contact with the attending resident and re-
mained stand, with slow pendulum movements, until finally felt down on the floor. She denied 
having any psychiatric disorder and repeated numerous times phrases like: “my throat is locked 
and nothing can be done about it”, “I have no blood in my veins or pulse in my arteries” and 
“the sun won’t rise up and the night won’t end”. 
After a complete clinical evaluation, in which any organic cause for the psychiatric symp-
toms was discarded, patient was admitted on the psychiatric inpatient floor, under the diagno-
sis of severe depression with psychotic symptoms, according to the world health organization’s 
tenth edition of the international classification of diseases (ICD-10)5. Because of her psychotic 
features and motor inhibition, a diagnosis of Cotard’s syndrome and catatonia was considered. 
Initial pharmacological prescription – once patient was admitted on the psychiatric uni-
ty – included olanzapine 10 mg/day, velafaxine 75 mg/day and lorazepan 2 mg 8/8h (which 
was maintained for about 2 weeks, but without response of the catatonic signs). Venlafaxine’s 
doses were increased up to 450 mg/day and mirtazapine was added to the final dose of 45 
mg. Association with aripiprazole was tried, still with no response of the catatonic, depressive 
or psychotic phenomena. Electroconvulsive therapy (ECT) was then initiated, and previous an-
tidepressants and antipsychotics substituted by tranylcypromine (60 mg) and quetiapine (600 
mg) respectively. 
ECT was performed two times a week, initially with bi-frontal stimuli, on the dosage of 
134.4 mC, without response after several sessions. Procedure was then changed to bi-temporal 
stimuli until the dosage of 864 mC. Patient began to show improvements after the 14th ses-
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sion of ECT and presented clinical remission of the psychotic 
and depressive symptoms, as well as weight gain, at the end 
of the 21th session, but presenting significantly secondary 
memory sequels. She received hospital discharge after five 
months of hospitalization and maintains outpatient care at 
a mood disorders specialized ambulatory from the same ser-
vice. 
Cotard’s syndrome is known as a rare and severe pre-
sentation of major depression and can be associated with 
catatonic symptoms2,3,4,6. Lorazepam is recognized for the 
treatment of catatonia5, as well as arypiprazole, but in this 
case, patient did not respond to these measures. Resistance 
of catatonic symptoms to BZD’s treatment and absent res-
ponse of the depressive and psychotic phenomena to pro-
per medications were indications of ECT treatment3,4,6,7.
 Association of ECT and MAOI was considered due to 
the severity of the case4. Proper monitoring of patient vital 
signs and diet were established in order to secure introduc-
tion of MAOI7,8. Long inpatient care was needed because 
of case’s severity and its subsequent clinical complications 
(mainly sacral eschar, dehydration and hypokalemia, due to 
immobility and food and water deprivation, respectively). It 
included medical care, nursery, psychological and occupa-
tional therapy, as well as familiar support.
We believe this case report is important due to its re-
levant, yet not frequent appearance in medical literature. 
Cotard’s syndrome is a potentially fatal condition and can 
implicate in a heavy burden to patient’s family and commu-
nity. The use of ECT, although frequently seen as a taboo by 
general public and even by colleagues of other medical spe-
cialties, has potential to change the course of this severe pa-
thology. Also, its characteristics can precipitate se veral other 
medical conditions as described in this case, and a multi-pro-
fessional healthcare team is necessary to proper recognition 
and management. 
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